We are live on ! Find out more
MCM

Mitchell Capital Management Portfolio holdings

AUM $657M
1-Year Est. Return 64.28%
This Fund
S&P 500
This Quarter Est. Return
-16.24%
1 Year Est. Return
+64.28%
3 Year Est. Return
+219.19%
5 Year Est. Return
+290.67%
10 Year Est. Return
+1,411.54%
AUM
$357M
AUM Growth
-$90M
Cap. Flow
-$9.59M
Cap. Flow %
-2.69%
Top 10 Hldgs %
34.57%
Holding
140
New
13
Increased
67
Reduced
32
Closed
20

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$3.4M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.17M
3
VST icon
Vistra
VST
+$2.53M
4
CPRT icon
Copart
CPRT
+$2.19M
5
EXC icon
Exelon
EXC
+$2.12M

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$3.09M
2
ISRG icon
Intuitive Surgical
ISRG
+$2.94M
3
RCL icon
Royal Caribbean
RCL
+$2.9M
4
CHTR icon
Charter Communications
CHTR
+$2.64M
5
GNRC icon
Generac Holdings
GNRC
+$2.57M

Sector Composition

Rank Sector Weight
1 Technology 24.83%
2 Healthcare 14.43%
3 Financials 11.78%
4 Consumer Discretionary 8.98%
5 Communication Services 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABT icon
51
Abbott
ABT
$193B
$2.5M 0.7%
22,962
+446
+2% +$50.6K
BLK icon
52
Blackrock
BLK
$180B
$2.41M 0.68%
3,955
+47
+1% +$30.6K
VST icon
53
Vistra
VST
$49.1B
$2.34M 0.66%
+102,382
New +$2.53M
MNST icon
54
Monster Beverage
MNST
$91.4B
$2.24M 0.63%
+96,500
New +$2.1M
MYRG icon
55
MYR Group
MYRG
$5.18B
$2.19M 0.61%
24,808
+669
+3% +$58.6K
APH icon
56
Amphenol
APH
$204B
$2.17M 0.61%
67,466
+2,266
+3% +$78.8K
RRX icon
57
Regal Rexnord
RRX
$11.4B
$2.16M 0.61%
19,035
-1,286
-6% -$164K
IDXX icon
58
Idexx Laboratories
IDXX
$44.7B
$2.15M 0.6%
6,127
-2,996
-33% -$1.22M
CPRT icon
59
Copart
CPRT
$27.2B
$2.08M 0.58%
+76,760
New +$2.19M
ACWX icon
60
iShares MSCI ACWI ex US ETF
ACWX
$12B
$2.06M 0.58%
45,889
+1,414
+3% +$68.4K
EXC icon
61
Exelon
EXC
$47B
$2.05M 0.57%
+45,195
New +$2.12M
HSY icon
62
Hershey
HSY
$37.4B
$1.99M 0.56%
+9,241
New +$2.01M
ORLY icon
63
O'Reilly Automotive
ORLY
$74.5B
$1.97M 0.55%
+46,770
New +$2.01M
AON icon
64
Aon
AON
$75.7B
$1.87M 0.52%
6,931
+50
+0.7% +$14.4K
KEYS icon
65
Keysight
KEYS
$60.6B
$1.87M 0.52%
13,534
+376
+3% +$53.5K
NVO
66
Novo Nordisk
NVO
$205B
$1.8M 0.51%
32,394
+298
+0.9% +$16.5K
ICE icon
67
Intercontinental Exchange
ICE
$87.2B
$1.79M 0.5%
19,013
-963
-5% -$103K
ACN icon
68
Accenture
ACN
$109B
$1.76M 0.49%
6,353
+57
+0.9% +$17.1K
DEO icon
69
Diageo
DEO
$52.8B
$1.73M 0.48%
9,911
+111
+1% +$21.1K
LRCX icon
70
Lam Research
LRCX
$422B
$1.71M 0.48%
40,100
+2,020
+5% +$96.2K
MLM icon
71
Martin Marietta Materials
MLM
$32.7B
$1.64M 0.46%
5,477
+141
+3% +$48.1K
FANG icon
72
Diamondback Energy
FANG
$55.9B
$1.61M 0.45%
+13,302
New +$1.82M
SHEL icon
73
Shell
SHEL
$248B
$1.58M 0.44%
30,186
+3,553
+13% +$200K
EME icon
74
Emcor
EME
$36.7B
$1.52M 0.43%
14,812
-14,168
-49% -$1.51M
DVN icon
75
Devon Energy
DVN
$48.8B
$1.47M 0.41%
+26,741
New +$1.75M
1 2
3
4 5

Similar funds

BL
BWCP LP Dallas, Texas $656M AUM 41.58% 1-Year Est. Return
PIM
Parker Investment Management Menlo Park, California $659M AUM 52.52% 1-Year Est. Return
ACM
Arosa Capital Management Miami Beach, Florida $660M AUM 210.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
FAM
Fulcrum Asset Management London, United Kingdom $662M AUM 48.09% 1-Year Est. Return
AG
Alibaba Group Causeway Bay, Hong Kong $653M AUM 16.11% 1-Year Est. Return
BCP
Bain Capital Prairie Boston, Massachusetts $666M AUM

Mitchell Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Mitchell Capital Management held 140 positions worth $357M, down 20% from $447M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Mitchell Capital Management's Q2 2022 filing shows 13 new, 67 increased, 32 reduced and 20 closed positions. Its largest new stake was Vertex Pharmaceuticals: 11,826 shares worth $3.33M. The largest sale was DuPont de Nemours, an estimated $3.09M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • Mitchell Capital Management's largest Q2 2022 buy was Vertex Pharmaceuticals: 11,826 shares worth $3.33M.
  • Mitchell Capital Management added most to Johnson & Johnson in Q2 2022, an estimated $3.4M increase.
  • Mitchell Capital Management's biggest Q2 2022 reduction was Costco, cutting an estimated $2.05M.
  • Mitchell Capital Management fully exited DuPont de Nemours in Q2 2022, selling an estimated $3.09M.
  • Mitchell Capital Management's ten largest holdings make up 35% of its $357M portfolio in Q2 2022.
  • Mitchell Capital Management opened 13 new positions and closed 20 in Q2 2022.
  • Mitchell Capital Management's portfolio value fell 20% quarter-over-quarter to $357M.

Based on Mitchell Capital Management's 13F filing for Q2 2022, filed 29 Jul 2022.